Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Both semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are effective GLP-1 medications for weight loss
CRISPR-Cas9: a history of its discovery and ethical considerations of its use in genome editing
Specifically, patents for semaglutide are due to expire starting later this month in India, China, Canada, Brazil, and Turkey, along with three other countries later this year, which is expected to spark distribution of generic versions
patents keep generics out until around 2031 or 2035, maintaining Novo Nordisks exclusivity and high prices Bookmark CommentsGo to comments Affordable, regulated versions of Ozempic, the well-known diabetes and weight-loss shot from Novo Nordisk, are about to hit markets around the world, which could shake up the obesity drug scene
Key takeaways Both tirzepatide and semaglutide are once-weekly injectable GLP-1 medications that produce significant weight loss and improve blood sugar control
US$ 28.44
US$ 29.06
US$ 25.01
